LON:EAH

ECO Animal Health Group Final Earnings Results & Report

ECO Animal Health Group logo
GBX 81.15 -5.85 (-6.72%)
As of 11:11 AM Eastern

ECO Animal Health Group reported Final earnings on July 14, 2025. The company reported EPS of GBX 2.49.

Earnings Announcement Details

Quarter
Final
Report Date
Time
Before Market Opens

ECO Animal Health Group EPS Results

Actual EPS
GBX 2.49
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ECO Animal Health Group Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

ECO Animal Health Group Final Earnings FAQ

ECO Animal Health Group (LON:EAH) reported earnings of GBX 2.49 per share for Final. The report was announced on Monday, July 14, 2025.

ECO Animal Health Group Earnings Headlines

Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
Didier Branellec appointed Non-Executive Director
See More ECO Animal Health Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ECO Animal Health Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ECO Animal Health Group and other key companies, straight to your email.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

View ECO Animal Health Group Profile